Lux is responsible for this startup’s branding, website, public relations, and investor outreach programs. Matrix-Bio has succeeded in licensing its breast cancer recurrence technology to Quest Diagnostics and is in a capital raise for a colon cancer diagnostic test.


View Project
www.Matrix-Bio.com
404